Hematological Parameters and Liver Function After COVID-19 Vaccination ( Simple Population Patients in Ramadi City – Iraq)
-
Published:2023-09-06
Issue:2
Volume:8
Page:
-
ISSN:2714-7444
-
Container-title:Academia Open
-
language:
-
Short-container-title:acopen
Author:
Ajeel Jasim Ridhab,Noori Saif Subhi,Mahmood Adeeb Shakir,Jumaa Asmaa Wajeh,Alkareem Fatin Zuher Abd
Abstract
This study aimed to investigate the influence of COVID-19 vaccination on liver function and blood parameters, specifically Mean Corpuscular Volume (MCV) and Hemoglobin (HGB) levels, among young adults (aged 18-32) in Anbar province. Blood samples from 50 individuals were collected at Ramadi Teaching Hospital, with half of the participants vaccinated and the other half unvaccinated. Results revealed a significant decrease in MCV and HGB levels among the vaccinated group compared to the unvaccinated group. Concurrently, liver function indicators, including Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP), and Bilirubin, showed a marked increase in the vaccinated individuals, indicating potential hematological disorders and liver injury. These findings underscore the importance of COVID-19 vaccination while highlighting the need for continued monitoring of liver health and blood parameters in vaccinated individuals to mitigate potential long-term health implications.
Highlights:
COVID-19 vaccination in young adults may lead to a significant decrease in Mean Corpuscular Volume (MCV) and Hemoglobin (HGB) levels.
Liver function indicators such as Alanine Aminotransferase (ALT), Alkaline Phosphatase (ALP), and Bilirubin exhibit a notable increase in vaccinated individuals.
Continuous monitoring of liver health and blood parameters is crucial for assessing potential long-term health implications associated with COVID-19 vaccination.
Keywords: COVID-19 Vaccination, Liver Function, Blood Parameters, Young Adults, Anbar Province.
Publisher
Universitas Muhammadiyah Sidoarjo
Reference27 articles.
1. C. Huang, Y. Wang, X. Li, L. Ren, J. Zhao, Y. Hu, et al., "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China," Lancet, 2020, pp. 497–506. 2. Z. Wu and J.M. McGoogan, "Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention," JAMA, vol. 323, no. 13, pp. 1239–1242, 2020. 3. C. Efe, R. Dhanasekaran, C. Lammert, B. Ebik, F. Higuera-dela Tijera, C. Aloman, et al., "Outcome of COVID-19 in patients with autoimmune hepatitis: an international multicenter study," Hepatology, vol. 73, pp. 2099–2109, 2021. 4. O. Sharma, A.A. Sultan, H. Ding, and C.R. Triggle, "A Review of the Progress and Challenges of Developing a Vaccine for COVID-19," Front. Immunol., vol. 11, p. 585354, 2020. 5. T. Fiolet, Y. Kherabi, C.J. MacDonald, J. Ghosn, and N. Peiffer-Smadja, "Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review," Clin. Microbiol. Infect., vol. 28, pp. 221–202, 2021.
|
|